Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

REGISTER for free or LOG IN to view this content

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

CAD Pharma

Heart Rhythm

Atrial Fibrillation

Structural Heart

Aortic Valve

Factoid

TAVR

Oral Anticoagulation

PARTNER

Up Next

Presentation

Minimizing Permanent Pacemaker (PPM) After a Repositionable Self-Expanding TAVR Device

August 29, 2019

More slides +

Presentation

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

Presenter: David B. Brieger

September 01, 2019

Presentation

A Risk Based Approach to the Role of Aspirin on Cardiovascular Risk Reduction in a Healthy Older Cohort

Presenter: Christopher M Reid

September 01, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.